Rachael Nokes
2020
In 2020, Rachael Nokes earned a total compensation of $640.6K as Senior Vice President of Finance at scPharmaceuticals, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $97,253 |
|---|---|
| Option Awards | $207,012 |
| Salary | $324,500 |
| Other | $11,789 |
| Total | $640,554 |
Nokes received $324.5K in salary, accounting for 51% of the total pay in 2020.
Nokes also received $97.3K in non-equity incentive plan, $207K in option awards and $11.8K in other compensation.
Rankings
In 2020, Rachael Nokes' compensation ranked 10,280th out of 13,090 executives tracked by ExecPay. In other words, Nokes earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,280 out of 13,090 | 22nd |
Division Manufacturing | 4,405 out of 5,618 | 22nd |
Major group Chemicals And Allied Products | 1,820 out of 2,251 | 19th |
Industry group Drugs | 1,592 out of 1,951 | 18th |
Industry Pharmaceutical Preparations | 1,176 out of 1,456 | 19th |
Source: SEC filing on April 27, 2021.
Nokes' colleagues
We found one more compensation record of an executive who worked with Rachael Nokes at scPharmaceuticals in 2020.
2020
John Tucker
scPharmaceuticals
Chief Executive Officer
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020